Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

• Asıl Yazarlar: Hu Li (Yazar), Nan-Nan Liu (Yazar), Jian-Rui Li (Yazar), Biao Dong (Yazar), Mei-Xi Wang (Yazar), Jia-Li Tan (Yazar), Xue-Kai Wang (Yazar), Jing Jiang (Yazar), Lei Lei (Yazar), Hong-Ying Li (Yazar), Han Sun (Yazar), Jian-Dong Jiang (Yazar), Zong-Gen Peng (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), is a liver disease worldwide without approved therapeutic drugs. Anti-inflammatory and hepatoprotective drug bicyclol and multi-pharmacological active drug berberine, respectively, have sh...